[go: up one dir, main page]

Skip to main content

Advertisement

Log in

Enodthelin 1 Is Elevated in Plasma and Explants From Patients Having Uterine Leiomyomas

  • Original Articles
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Objective

To determine a role for endothelin (ET) in progression of uterine fibroids.

Design

An in vitro model of fibroid and myometrium cultivation.

Patients

A total of 32 women undergoing hysterectomies for uterine fibroids and 11 women undergoing hysterectomies for abnormal uterine bleeding (control population).

Results

Women with uterine fibroids were hypertensive and displayed significantly greater circulating ET-1 compared to control patients. Secretion of ET-1 was greater from the fibroids compared to myometrium explants. Endothelin 1 secretion was attenuated with blockade of the angiotensin II type 1 or endothelinA receptors. Hypoxia stimulated ET-1 secretion from both myometrium and fibroid explants. Preproendothelin messenger RNA expression increased with hypoxia from fibroid explants compared to normoxic controls.

Conclusions

These data support the hypothesis that uterine fibroids are associated with hypertension and increased ET-1, which is exacerbated with hypoxia. These data suggest a possible link between mechanisms of blood pressure regulation and development of uterine leiomyoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Parazzini F, Chiaffarino F, Polverino G, Chiantera V, Surace M, La Vecchia C. Uterine fibroids risk and history of selected medical conditions linked with female hormones. Eur J Epidemiol. 2004;19(3):249–253.

    Article  PubMed  Google Scholar 

  2. Mauskopf J, Flynn M, Thieda P, Spalding J, Duchane J. The economic impact of uterine fibroids in the United States: a summary of published estimates. J Womens Health (Larchmt) 2005;14(8):692–703.

    Article  Google Scholar 

  3. Zimmerman A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012;12:1–11.

    Article  Google Scholar 

  4. Farquhar C, Steiner C. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol. 2002;99(2):229–234.

    PubMed  Google Scholar 

  5. Wilcox L, Koonin L, Pokras R, Strauss L, Xia Z, Petersion H. Hysterectomy in the United States, 1988–1990. Obstet Gynecol. 1994;83(4):549–555.

    Article  CAS  PubMed  Google Scholar 

  6. Flake G, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111(8): 1037–1054

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer S, Wright R. A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol. 2005;161(7):628–638.

    Article  PubMed  Google Scholar 

  8. Silver A, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: Potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich). 2005;7(11):664–668.

    Article  Google Scholar 

  9. Settnes A, Andreasen A, Jorgensen T. Hypertension is associated with an increased risk for hysterectomy: a Danish cohort study. Eur J Obstet Gynecol Reprod Biol. 2005;122(2):218–224.

    Article  PubMed  Google Scholar 

  10. Tanfin Z, Ieiber D, Robin P, Oyeniran C, Breuiller-Fouche M. Endothelin-1: Physiological and pathological roles in myometrium. Int J Biochem Cell Biol. 2011;43(3):299–302.

    Article  CAS  PubMed  Google Scholar 

  11. Isobe A, Takeda T, Sakata M, et al. Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation. Hum Reprod. 2008;23(2):440–446.

    Article  CAS  PubMed  Google Scholar 

  12. Murphy S, LaMarca B, Cockrell K, Granger J. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension. 2010;55(2):394–398.

    Article  CAS  PubMed  Google Scholar 

  13. Zhou S, Yi T, Shen K, Zhang B, Huang F, Zhao X. Hypoxia: The driving force of uterine myometrial stem cells differentiation into leiomyoma cells. Med Hypotheses. 2011;77(6):985–986.

    Article  PubMed  Google Scholar 

  14. Mayer A, Hockel M, von Wallbrunn A, Horn LC, Wree A, Vaupel P. HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas. Adv Exp Med Biol. 2010;662:399–405.

    Article  CAS  PubMed  Google Scholar 

  15. Mayer A, Hockel M, Wree A, Leo C, Horn LC, Vaupel P. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res. 2008;68(12):4719–4726.

    Article  CAS  PubMed  Google Scholar 

  16. Fletcher N, Saed M, Abu-Soud H, Al-Hendy A, Diamond M, Saed G. Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids. J Assist Reprod Genet. 2013;30(7):969–974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chang H, Senaratnea T, Zhang L, et al. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reprod Sci. 2010;17(2): 158–167.

    Article  PubMed  Google Scholar 

  18. LaMarca B, Alexander B, Gilbert J, Ryan M, Sedeek M, Granger J. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gender Med. 2008;5(suppl A):S133–S138.

    Article  Google Scholar 

  19. Lerman A, Kubo S, Tschumperlin L, Burnett JJ. Plasma endothelin concentrations in humans with end-stage heart failure and after heart-transplantation. J Am Coll Cardiol. 1992;20(4):849–853.

    Article  CAS  PubMed  Google Scholar 

  20. Pekonen F, Nyman T, Rutanen R. Differential expression of mRNAs for endothelin-related proteins in human endometrium, myometrium and leiomyoma. Mol Cell Endocrinol. 1994;103(1–2):165–170.

    Article  CAS  PubMed  Google Scholar 

  21. CDC. Data Trends & Maps Web site. US Department of Health and Human Services, Centers for Diseases Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Division for Heart Disease and Stroke Prevention. 2009;2009

  22. Wallace K, Novotny S, Heath J, et al. Hypertension in response to CD4+ T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol. 2012;303(2):R144–R149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lamarca B, Wallace K, Herse F, et al. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension. 2011;57(4):864–871.

    Article  CAS  Google Scholar 

  24. LaMarca B, Cockrell K, Sullivan E, Bennett W, Granger J. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46(1):82–86.

    Article  CAS  PubMed  Google Scholar 

  25. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DeltaDeltaCt Method. Methods. 2001;25(4):402–408.

    Article  CAS  PubMed  Google Scholar 

  26. Mauricio M, Aldasoro M, Ortega J, Vila J. Endothelial dysfunction in morbid obesity. Curr Pharm Des. 2013;19(32):5718–5729.

    Article  CAS  PubMed  Google Scholar 

  27. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag. 2008;4(5):1061–1068.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Vanhoutte P. Is endothelin involved in the pathogenesis of hypertension? Hypertension. 1993;21(6 pt 1):747–751.

    Article  CAS  PubMed  Google Scholar 

  29. Isobe A, Takeda T, Wakabayashi A, et al. Aldosterone stimulates the proliferation of uterine leiomyoma cells. Gynecol Endocrinol. 2010;26(5):372–377.

    Article  CAS  PubMed  Google Scholar 

  30. Keith B, Simon M. Hypoxia-inducible factors, stem cells and cancer. Cell. 2007;129(3):465–472.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Guyton A, Hall J. Textbook of Medical Physiology. Philadelphia: WB Saunders Company; 2000.

    Google Scholar 

  32. Cameron I, Bacon C, Collett G, Davenport A. Endothelin expression in the uterus. J Steriod Biochem Mol Biol. 1995;53(1–6):209–214.

    Article  CAS  Google Scholar 

  33. Granger J, Abram S, Stec D, Chandler D, LaMarca B. Endothelin, the kidney and hypertension. Curr Hypertens Rep. 2006;8(4):298–303.

    Article  CAS  PubMed  Google Scholar 

  34. Smollich M, Wulfing P. The endothelin axis: A novel target for pharmacotherapy of female malignancies. Curr Vasc Pharmacol. 2007;5(3):239–248.

    Article  CAS  PubMed  Google Scholar 

  35. Bagnato A, Rosano L. The endothelin axis in cancer. Int J Bio-chem Cell Biol. 2008;40(8):1443–1451.

    Article  CAS  PubMed  Google Scholar 

  36. Tanfin Z, Breuiller-Fouche M. The endothelin axis in uterine leiomyomas: new insights. Biol Reprod. 2012;87(1):5.

    Article  PubMed  CAS  Google Scholar 

  37. Raymond M, Robin P, De Zen F, Vilain G, Tanfin Z. Differential endothelin receptor expression and function in rat myometrial cells and leiomyoma ELT3 cells. Endocrinology. 2009;150(10): 4766–4776.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Dohi Y, Kojima M, Sato K. Endothelial modulation of contractile responses in arteries from hypertensive rats. Hypertension. 1996; 28(5):732–737.

    Article  CAS  PubMed  Google Scholar 

  39. Karumanchi A, Bdolah Y. Hypoxia and sFlt-1 in Preeclampsia: The ‘‘Chicken-and-Egg’’ question. Endocrinology. 2004;145(11): 4835–4837.

    Article  CAS  PubMed  Google Scholar 

  40. Luoto R, Rutanen E, Auvinen A. Fibroids and hypertension. A cross-sectional study of women undergoing hysterectomy. J Reprod Med. 2001;46(4):359–364.

    CAS  PubMed  Google Scholar 

  41. Moorman P, Leppert P, Myers E, Wang F. Comparision of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy. Fertil Steril. 2013; 99(3):768–776.

    Article  PubMed  Google Scholar 

  42. Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG. 2003;109(10):1097–1108.

    Article  Google Scholar 

  43. Halder S, Osteen K, Al-Hendy A. Vitamin D3 inhibits expression and activities of matric metalloproteinase-2 and -9 in human uterine fibroid cells. Human Rep. 2013;28(9):2407–2416.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Babbette LaMarca PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wallace, K., Chatman, K., Porter, J. et al. Enodthelin 1 Is Elevated in Plasma and Explants From Patients Having Uterine Leiomyomas. Reprod. Sci. 21, 1196–1205 (2014). https://doi.org/10.1177/1933719114542018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719114542018

Keywords

Navigation